Unaudited consolidated interim accounts for the third quarter and first nine months of 2026

Unaudited third-quarter 2026 revenue rose 8.2% year over year to €251.7 million, while profit before tax fell 11.7% to €7.1 million. For the first nine months, revenue increased 8.1% to €735.2 million from €680.4 million, while profit before tax declined 4.2% to €15.3 million.

Analysis

The key signal is operating leverage moving the wrong way: implied pre-tax margin fell about 64 bps year over year in Q3 and about 27 bps over the first nine months. That makes the sales growth lower quality until management shows whether the gap reflects temporary costs or persistent pricing, mix, or cost inflation. The nine-month deterioration suggests the issue is not confined to one quarter, though the data do not identify its cause.

Near term, the next results and any guidance on pricing, input costs, and cost control are the catalysts. Over 6–18 months, sustained revenue growth without margin recovery would weaken the case for earnings compounding and could constrain valuation support; conversely, stabilization in pre-tax margin would validate investment-led or mix-driven growth. The release is unaudited, and revenue/PBT alone do not establish cash conversion or the source of margin pressure. With no company identity, valuation, or ticker supplied, there is no defensible security-specific trade. The contrarian angle is that topline growth may look reassuring while masking deteriorating incremental profitability.

Key Decisions for Investors

• No trade on this release alone. Obtain the company identity, current valuation, and segment data before translating the signal into a position.
• At the next reporting date, verify whether gross margin and operating costs explain the pre-tax margin decline; also check cash conversion, working capital, and whether the trend differs by segment.
• Treat recovery in pre-tax margin alongside continued revenue growth as a potential positive catalyst; treat another year-over-year decline in margin or a guidance cut as thesis confirmation for a more cautious view.
• Avoid extrapolating the revenue growth rate into earnings growth unless management provides evidence that pricing, mix, or cost actions are restoring incremental profitability.